What Happens Next in the Mifepristone Abortion Drug Casenews2023-04-12T16:55:09+00:00April 12th, 2023|The New York Times|
After Texas Ruling, Democratic States Move to Stockpile Abortion Pillsnews2023-04-12T14:11:19+00:00April 12th, 2023|The New York Times|
Abortion Pill Ruling: Read Annotated Excerpts From F.D.A. Casenews2023-04-12T02:32:14+00:00April 12th, 2023|The New York Times|
Pfizer CEO and Other Drug Company Leaders Condemn Texas Abortion Pill Rulingnews2023-04-11T11:21:49+00:00April 11th, 2023|The New York Times|
What Is Mounjaro, the Diabetes Drug That Could Overshadow Ozempic?news2023-04-11T09:00:16+00:00April 11th, 2023|The New York Times|
I Worked at the F.D.A. The Abortion Pill Decision Is Dangerous.news2023-04-10T22:55:57+00:00April 10th, 2023|The New York Times|
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authoritynews2023-04-10T07:00:09+00:00April 10th, 2023|The New York Times|
The Abortion Pill Ruling Is Bad Law, and the Biden Administration Should Fight Itnews2023-04-09T09:00:12+00:00April 9th, 2023|The New York Times|
